Myrtelle, Inc., a clinical-stage gene therapy company selected by the FDA for the START Pilot Program and focused on developing treatments for neurodegenerative diseases, today announced its ...

The report highlights opportunities in optimizing location strategies for Eosinophilic Esophagitis trials, leveraging enrollment trends, and assessing trial success rates. It aids strategic investment ...

The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with ...

Techcyte, developer of the Fusion unified digital pathology platform, and Biobase, creator of an agentic data discovery platform for connecting multi-modal clinical data to pharma and research buyers, ...

Initial clinical data demonstrated 71% ACR50 response in refractory rheumatoid arthritis (RA) patients with at least six months of follow-up in ...

Bellevue, Wash.-based health data company Truveta announced Truveta Intelligence, a new AI-powered tool that lets researchers ...

Clinical data review is the continuous process of evaluating clinical trial data for accuracy, completeness, consistency, and clinical relevance as it is collected, ensuring data quality and early ...

We are excited to discuss encouraging initial safety data from the first participant in our Phase 1/2 clinical trial of ...

Phase 1 Clinical Data Demonstrate Dose-Proportional PK, No Dose-Limiting Toxicities Through Four Dose Levels, and Concordance with Preclinical PBPK Predictions ...

"We estimate that there are approximately 20,000 addressable patients who are HER2-positive and overexpress CD47, representing a $2 billion to $4 billion market opportunity in the United States, the 5 ...

Interested in participating in exercise research? We are looking for volunteers for various exercise-based studies to help understand the role of exercise as medicine at the molecular, cellular and ...